EA200201223A1 - Тиенодибензоазуленовые соединения в качестве ингибиторов фактора некроза опухоли - Google Patents

Тиенодибензоазуленовые соединения в качестве ингибиторов фактора некроза опухоли

Info

Publication number
EA200201223A1
EA200201223A1 EA200201223A EA200201223A EA200201223A1 EA 200201223 A1 EA200201223 A1 EA 200201223A1 EA 200201223 A EA200201223 A EA 200201223A EA 200201223 A EA200201223 A EA 200201223A EA 200201223 A1 EA200201223 A1 EA 200201223A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
necrosis factor
tumor necrosis
tienodibenzoesulene
inhibitors
Prior art date
Application number
EA200201223A
Other languages
English (en)
Other versions
EA006069B1 (ru
Inventor
Младен Мерчеп
Милан Месич
Дияна Пешич
Желько Жупанович
Бошка Хрвачич
Original Assignee
Плива, Фармацойтска Индустрия, Дионичко Друштво
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Плива, Фармацойтска Индустрия, Дионичко Друштво filed Critical Плива, Фармацойтска Индустрия, Дионичко Друштво
Publication of EA200201223A1 publication Critical patent/EA200201223A1/ru
Publication of EA006069B1 publication Critical patent/EA006069B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Настоящее изобретение относится к соединениям дибензоазулена, представленным формулой I, а также к их фармацевтическим композициями для ингибирования альфа-фактора некроза опухолей (TNF-α) и интерлейкина 1 (IL-1) у животных при всех заболеваниях и состояниях, у которых эти медиаторы чрезмерно секретируются. Соединения настоящего изобретения демонстрируют также анальгетическое действие и могут применяться для уменьшения боли.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200201223A 2000-05-17 2001-05-16 Тиенодибензоазуленовые соединения в качестве ингибиторов фактора некроза опухоли EA006069B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20000310A HRP20000310A2 (en) 2000-05-17 2000-05-17 New dibenzoazulene compounds as tumor necrosis factor inhibitors
PCT/HR2001/000027 WO2001087890A1 (en) 2000-05-17 2001-05-16 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors

Publications (2)

Publication Number Publication Date
EA200201223A1 true EA200201223A1 (ru) 2003-06-26
EA006069B1 EA006069B1 (ru) 2005-08-25

Family

ID=10947110

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200201223A EA006069B1 (ru) 2000-05-17 2001-05-16 Тиенодибензоазуленовые соединения в качестве ингибиторов фактора некроза опухоли

Country Status (37)

Country Link
US (2) US6897211B2 (ru)
EP (1) EP1284977B1 (ru)
JP (1) JP2003533528A (ru)
KR (1) KR100823064B1 (ru)
CN (1) CN1194976C (ru)
AR (1) AR030562A1 (ru)
AT (1) ATE434619T1 (ru)
AU (2) AU2001256560B2 (ru)
BG (1) BG65967B1 (ru)
BR (1) BR0111202A (ru)
CA (1) CA2409090C (ru)
CR (1) CR6860A (ru)
CY (1) CY1109328T1 (ru)
CZ (1) CZ301770B6 (ru)
DE (1) DE60139070D1 (ru)
DK (1) DK1284977T3 (ru)
DZ (1) DZ3357A1 (ru)
EA (1) EA006069B1 (ru)
EE (1) EE200200636A (ru)
ES (1) ES2328335T3 (ru)
GE (1) GEP20043304B (ru)
HK (1) HK1056719A1 (ru)
HR (1) HRP20000310A2 (ru)
HU (1) HUP0302295A3 (ru)
IL (1) IL152809A0 (ru)
IS (1) IS6621A (ru)
MA (1) MA27125A1 (ru)
MX (1) MXPA02011269A (ru)
NO (1) NO20025510L (ru)
NZ (1) NZ522553A (ru)
PL (1) PL204849B1 (ru)
PT (1) PT1284977E (ru)
RS (1) RS50893B (ru)
SI (1) SI1284977T1 (ru)
SK (1) SK17702002A3 (ru)
WO (1) WO2001087890A1 (ru)
ZA (1) ZA200209180B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020303B8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020440B1 (en) * 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020441A2 (en) * 2002-05-21 2003-12-31 Pliva D D 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020451A2 (en) 2002-05-23 2003-12-31 Pliva D D 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20020452A2 (en) * 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20020453A2 (en) 2002-05-23 2003-12-31 Pliva D D 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
WO2005047274A1 (en) * 2003-11-12 2005-05-26 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
US20090048221A1 (en) 2004-10-27 2009-02-19 Mladen Mercep Conjugates with Anti-Inflammatory Activity
WO2006061392A2 (en) * 2004-12-07 2006-06-15 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
JP2008532927A (ja) * 2005-01-13 2008-08-21 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗炎症マクロライド接合体
JP2009529057A (ja) 2006-03-08 2009-08-13 コートリア・コーポレーシヨン Ｃｏｘ−関連胃損傷を予防するための非−選択的ｃｏｘ阻害剤との組み合わせ療法
US8389482B2 (en) 2007-01-30 2013-03-05 New York University Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species
WO2008096755A1 (ja) * 2007-02-07 2008-08-14 Nippon Suisan Kaisha, Ltd. バニロイド受容体（ｖｒ１）阻害剤及びその用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
JPS53116385A (en) * 1977-03-19 1978-10-11 Hokuriku Pharmaceutical Pyrazin derivative and method for its production
US4198421A (en) * 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
TR199801164T2 (xx) * 1996-04-12 1998-10-21 Janssen Pharmaceutica N.V. S�bstit�e edilmi� tetrasiklik tetrahidrofuran t�revleri.
GB9713368D0 (en) * 1997-06-25 1997-08-27 Weston Medical Ltd Flame control
EP0887339A1 (de) * 1997-06-27 1998-12-30 Roche Diagnostics GmbH Neue Azulenderivate und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
DE60139070D1 (de) 2009-08-06
US20030153750A1 (en) 2003-08-14
US20050171091A1 (en) 2005-08-04
KR100823064B1 (ko) 2008-04-18
BR0111202A (pt) 2003-04-01
AR030562A1 (es) 2003-08-27
EP1284977B1 (en) 2009-06-24
EA006069B1 (ru) 2005-08-25
NZ522553A (en) 2005-04-29
CZ301770B6 (cs) 2010-06-16
US6897211B2 (en) 2005-05-24
KR20030010625A (ko) 2003-02-05
SI1284977T1 (sl) 2009-10-31
EE200200636A (et) 2004-04-15
ATE434619T1 (de) 2009-07-15
WO2001087890A1 (en) 2001-11-22
CR6860A (es) 2008-06-02
DZ3357A1 (fr) 2001-11-22
HUP0302295A2 (hu) 2003-10-28
PL365054A1 (en) 2004-12-27
CZ20024090A3 (cs) 2003-05-14
ES2328335T3 (es) 2009-11-12
MXPA02011269A (es) 2003-06-06
DK1284977T3 (da) 2009-09-14
NO20025510L (no) 2003-01-14
CA2409090C (en) 2010-06-29
CN1194976C (zh) 2005-03-30
PL204849B1 (pl) 2010-02-26
RS50893B (sr) 2010-08-31
MA27125A1 (fr) 2005-01-03
CY1109328T1 (el) 2012-05-23
GEP20043304B (en) 2004-02-10
AU2001256560B2 (en) 2005-10-06
CN1437605A (zh) 2003-08-20
CA2409090A1 (en) 2001-11-22
BG107399A (bg) 2003-09-30
SK17702002A3 (sk) 2003-10-07
HUP0302295A3 (en) 2007-03-28
HRP20000310A2 (en) 2002-02-28
HK1056719A1 (en) 2004-02-27
PT1284977E (pt) 2009-09-09
IS6621A (is) 2002-11-14
JP2003533528A (ja) 2003-11-11
IL152809A0 (en) 2003-06-24
NO20025510D0 (no) 2002-11-15
EP1284977A1 (en) 2003-02-26
AU5656001A (en) 2001-11-26
BG65967B1 (bg) 2010-07-30
YU84102A (sh) 2006-01-16
ZA200209180B (en) 2003-11-12

Similar Documents

Publication Publication Date Title
EA200201223A1 (ru) Тиенодибензоазуленовые соединения в качестве ингибиторов фактора некроза опухоли
EA200400595A1 (ru) Бензимидазолы, применяемые в качестве ингибиторов протеинкиназы
EA200400953A1 (ru) Замещённые пиридиноны в качестве модуляторов map-киназы p38
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
EA200200058A1 (ru) Пиримидин-2,4,6-трионовые ингибиторы металлопротеиназ
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
EA200300306A1 (ru) Спиропиримидин-2,4,6-трионовые ингибиторы металлопротеиназы
EA200400971A1 (ru) Фторзамещенные циклоалканоиндолы, композиции, содержащие такие соединения, и способы лечения
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
EA200601239A1 (ru) Замещённые хинолиновые соединения
EA200100867A1 (ru) Сульфаматогидроксамовая кислота как ингибитор металлопротеаз
EA200300409A1 (ru) Пиримидин-2,4,6-трионовые ингибиторы металлопротеиназы
EA200000871A1 (ru) Ингибиторы фосфолипазных ферментов
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
DE69512797T2 (de) Prostaglandin-synthase hemmer
EA200001224A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
ATE396973T1 (de) Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit
EA200501399A1 (ru) Производные бензопирана, которые могут использоваться при лечении воспалительных заболеваний
EA200500377A1 (ru) Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf)
EA200101036A1 (ru) Противовоспалительные и иммуносупрессорные соединения, ингибирующие клеточную адгезию
EA200500849A1 (ru) Новые соединения лапахона и способы их применения
EA199900057A1 (ru) Ингибиторы матриксных металлопротеиназ

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU